Farallon Capital Partners L.P. 13D/13G Filings for Tyra Biosciences, Inc. (TYRA)

Farallon Capital Partners L.P. 13D and 13G filings for Tyra Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-20
08:14 am
Purchase
2026-02-1213GTyra Biosciences, Inc.
TYRA
Farallon Capital Partners L.P.2,984,818
5.600%
2,984,818increase
(New Position)
Filing